整合应激反应在阿尔茨海默病发病中作用的研究进展

doi:10.3969/j.issn.1674-8115.2023.06.012

上海交通大学学报（医学版） ›› 2023, Vol. 43 ›› Issue (6): 755-760.doi: 10.3969/j.issn.1674-8115.2023.06.012

• 综述 • 上一篇

整合应激反应在阿尔茨海默病发病中作用的研究进展

孙慧(), 金宏福, 郭沈睿, 冯奕源, 尹雅芙, 王辉, 程维维()

上海交通大学医学院附属新华医院核医学科，心血管发育与再生医学研究所，上海 200092

收稿日期:2023-02-21 接受日期:2023-04-18 出版日期:2023-06-28 发布日期:2023-06-28
通讯作者: 程维维 E-mail:shshshe@sjtu.edu.cn;wcheng37@outlook.com
作者简介:孙慧（1999—），女，硕士生；电子信箱：shshshe@sjtu.edu.cn。
基金资助:
国家自然科学基金(81901162);上海市科委基金(20QA1406300)

Research progress of integrated stress response in pathogenesis of Alzheimer's disease

SUN Hui(), JIN Hongfu, GUO Shenrui, FENG Yiyuan, YIN Yafu, WANG Hui, CHENG Weiwei()

Department of Nuclear Medicine/Institute of Cardiovascular Development and Regenerative Medicine, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China

Received:2023-02-21 Accepted:2023-04-18 Online:2023-06-28 Published:2023-06-28
Contact: CHENG Weiwei E-mail:shshshe@sjtu.edu.cn;wcheng37@outlook.com
Supported by:
National Natural Science Foundation of China(81901162);Foundation of Science and Technology Commission of Shanghai Municipality(20QA1406300)

摘要/Abstract

摘要：

整合应激反应是细胞受到应激刺激后产生的适应性反应，由多个磷酸激酶、磷酸酶及其他蛋白严格调控，从而维持蛋白质稳态。研究表明在阿尔茨海默病中整合应激反应被异常激活；靶向调控整合应激反应通路的不同蛋白则可抑制异常激活的整合应激反应，恢复蛋白质稳态，并缓解阿尔茨海默病模型的神经病理改变及记忆障碍。这些证据提示整合应激反应或许可成为干预阿尔茨海默病病程的新靶点。该文对整合应激反应在阿尔茨海默病中的异常激活、调控机制，以及以其为靶点在阿尔茨海默病相关模型中的研究现状进行了综述。

关键词: 整合应激反应, 阿尔茨海默病, 整合应激反应抑制剂, 蛋白质稳态

Abstract:

Integrated stress response (ISR) is a cellular adaptive response induced by stress, which is strictly regulated by multiple phosphokinases, phosphatases and other proteins to maintain protein homeostasis. Studies have shown that ISR is abnormally activated in Alzheimer's disease, and targeted regulation of different proteins in ISR pathway inhibits the abnormal activation of ISR, leading to restoration of protein homeostasis and alleviation of the neuropathological changes and memory impairment in Alzheimer's disease models. These lines of evidence suggest that ISR has the potential to be a therapeutic target in Alzheimer's disease treatment. This paper reviews the abnormal activation and regulation mechanism of ISR in Alzheimer's disease and discusses the application of ISR as therapeutic targets to Alzheimer's disease models.

Key words: integrated stress response, Alzheimer disease, integrated stress response inhibitor, protein homeostasis

中图分类号:

R742

孙慧, 金宏福, 郭沈睿, 冯奕源, 尹雅芙, 王辉, 程维维. 整合应激反应在阿尔茨海默病发病中作用的研究进展[J]. 上海交通大学学报（医学版）, 2023, 43(6): 755-760.

SUN Hui, JIN Hongfu, GUO Shenrui, FENG Yiyuan, YIN Yafu, WANG Hui, CHENG Weiwei. Research progress of integrated stress response in pathogenesis of Alzheimer's disease[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(6): 755-760.

参考文献 42

1	GBD 2019 DEMENTIA FORECASTING COLLABORATORS. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019[J]. Lancet Public Health, 2022, 7(2): e105-e125.
2	ASSOCIATION A. 2008 Alzheimer's disease facts and figures[J]. Alzheimer's Dement, 2008, 4(2): 110-133.
3	HARDING H P, ZHANG Y, ZENG H, et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress[J]. Mol Cell, 2003, 11(3): 619-633.
4	COSTA-MATTIOLI M, WALTER P. The integrated stress response: from mechanism to disease[J]. Science, 2020, 368(6489): eaat5314.
5	ALGIRE M A, MAAG D, LORSCH J R. Pi release from eIF2, not GTP hydrolysis, is the step controlled by start-site selection during eukaryotic translation initiation[J]. Mol Cell, 2005, 20(2): 251-262.
6	KENNER L R, ANAND A A, NGUYEN H C, et al. eIF2B-catalyzed nucleotide exchange and phosphoregulation by the integrated stress response[J]. Science, 2019, 364(6439): 491-495.
7	OLIVEIRA M M, KLANN E. eIF2-dependent translation initiation: memory consolidation and disruption in Alzheimer's disease[J]. Semin Cell Dev Biol, 2022, 125:101-109.
8	GARCÍA-JIMÉNEZ C, GODING C R. Starvation and pseudo-starvation as drivers of cancer metastasis through translation reprogramming[J]. Cell Metab, 2019, 29(2): 254-267.
9	VERGINADIS I I, AVGOUSTI H, MONSLOW J, et al. A stromal integrated stress response activates perivascular cancer-associated fibroblasts to drive angiogenesis and tumour progression[J]. Nat Cell Biol, 2022, 24(6): 940-953.
10	CHATTOPADHYAY A, KWARTLER C S, KAW K, et al. Cholesterol-induced phenotypic modulation of smooth muscle cells to macrophage/fibroblast-like cells is driven by an unfolded protein response[J]. Arterioscler Thromb Vasc Biol, 2021, 41(1): 302-316.
11	SCHEUNER D, SONG B, MCEWEN E, et al. Translational control is required for the unfolded protein response and in vivo glucose homeostasis[J]. Mol Cell,2001,7(6):1165-1176.
12	WEK R C. Role of eIF2α kinases in translational control and adaptation to cellular stress[J]. Cold Spring Harb Perspect Biol, 2018, 10(7): a032870.
13	SANTOS-RIBEIRO D, GODINAS L, PILETTE C, et al. The integrated stress response system in cardiovascular disease[J]. Drug Discov Today, 2018, 23(4): 920-929.
14	MORADI MAJD R, MAYELI M, RAHMANI F. Pathogenesis and promising therapeutics of Alzheimer disease through eIF2α pathway and correspondent kinases[J]. Metab Brain Dis, 2020, 35(8): 1241-1250.
15	MA T, TRINH M A, WEXLER A J, et al. Suppression of eIF2α kinases alleviates Alzheimer's disease-related plasticity and memory deficits[J]. Nat Neurosci, 2013, 16(9): 1299-1305.
16	TIBLE M, MOUTON LIGER F, SCHMITT J, et al. PKR knockout in the 5xFAD model of Alzheimer's disease reveals beneficial effects on spatial memory and brain lesions[J]. Aging Cell, 2019, 18(3): e12887.
17	WONG Y L, LEBON L, BASSO A M, et al. eIF2B activator prevents neurological defects caused by a chronic integrated stress response[J]. Elife, 2019, 8: e42940.
18	JOUSSE C, OYADOMARI S, NOVOA I, et al. Inhibition of a constitutive translation initiation factor 2α phosphatase, CReP, promotes survival of stressed cells[J]. J Cell Biol, 2003, 163(4): 767-775.
19	NOVOA I, ZENG H, HARDING H P, et al. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2α[J]. J Cell Biol, 2001, 153(5): 1011-1022.
20	MORENO J A, RADFORD H, PERETTI D, et al. Sustained translational repression by eIF2α-P mediates prion neurodegeneration[J]. Nature, 2012, 485(7399): 507-511.
21	JAWAID A, WOLDEMICHAEL B T, KREMER E A, et al. Memory decline and its reversal in aging and neurodegeneration involve miR-183/96/182 biogenesis[J]. Mol Neurobiol, 2019, 56(5): 3451-3462.
22	CHANG R C, WONG A K, NG H K, et al. Phosphorylation of eukaryotic initiation factor-2α (eIF2α) is associated with neuronal degeneration in Alzheimer's disease[J]. Neuroreport, 2002, 13(18): 2429-2432.
23	O'CONNOR T, SADLEIR K R, MAUS E, et al. Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis[J]. Neuron, 2008, 60(6): 988-1009.
24	HU Z, YU P, ZHANG Y, et al. Inhibition of the ISR abrogates mGluR5-dependent long-term depression and spatial memory deficits in a rat model of Alzheimer's disease[J]. Transl Psychiatry, 2022, 12(1): 96.
25	HAYAKAWA M, ITOH M, OHTA K, et al. Quercetin reduces eIF2α phosphorylation by GADD34 induction[J]. Neurobiol Aging, 2015, 36(9): 2509-2518.
26	RADFORD H, MORENO J A, VERITY N, et al. PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementia[J]. Acta Neuropathol, 2015, 130(5): 633-642.
27	TCW J, QIAN L, PIPALIA N H, et al. Cholesterol and matrisome pathways dysregulated in astrocytes and microglia[J]. Cell, 2022, 185(13): 2213-2233.
28	OLIVEIRA M M, LOURENCO M V. Integrated stress response: connecting ApoE4 to memory impairment in Alzheimer's disease[J]. J Neurosci, 2016, 36(4): 1053-1055.
29	NAKAGAWA T, OHTA K. Quercetin regulates the integrated stress response to improve memory[J]. Int J Mol Sci, 2019, 20(11): E2761.
30	KASAI S, YAMAZAKI H, TANJI K, et al. Role of the ISR-ATF4 pathway and its cross talk with Nrf2 in mitochondrial quality control[J]. J Clin Biochem Nutr, 2019, 64(1): 1-12.
31	LOPEZ-GRANCHA M, BERNARDELLI P, MOINDROT N, et al. A novel selective PKR inhibitor restores cognitive deficits and neurodegeneration in Alzheimer disease experimental models[J]. J Pharmacol Exp Ther, 2021, 378(3): 262-275.
32	LI J, GAO L, CHEN J, et al. Mitochondrial ROS-mediated ribosome stalling and GCN2 activation are partially involved in 1-nitropyrene-induced steroidogenic inhibition in testes[J]. Environ Int, 2022, 167: 107393.
33	ANAND A A, WALTER P. Structural insights into ISRIB, a memory-enhancing inhibitor of the integrated stress response[J]. Febs J, 2020, 287(2): 239-245.
34	RABOUW H H, LANGEREIS M A, ANAND A A, et al. Small molecule ISRIB suppresses the integrated stress response within a defined window of activation[J]. Proc Natl Acad Sci USA, 2019, 116(6): 2097-2102.
35	HOSOI T, KAKIMOTO M, TANAKA K, et al. Unique pharmacological property of ISRIB in inhibition of Aβ-induced neuronal cell death[J]. J Pharmacol Sci, 2016, 131(4): 292-295.
36	OLIVEIRA M M, LOURENCO M V, LONGO F, et al. Correction of eIF2-dependent defects in brain protein synthesis, synaptic plasticity, and memory in mouse models of Alzheimer's disease[J]. Sci Signal, 2021, 14(668): eabc5429.
37	KRUKOWSKI K, NOLAN A, FRIAS E S, et al. Small molecule cognitive enhancer reverses age-related memory decline in mice[J]. Elife, 2020, 9: e62048.
38	TSAYTLER P, HARDING H P, RON D, et al. Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis[J]. Science, 2011, 332(6025): 91-94.
39	SINGH A, GUPTA P, TIWARI S, et al. Guanabenz mitigates the neuropathological alterations and cell death in Alzheimer's disease[J]. Cell Tissue Res, 2022, 388(2): 239-258.
40	RUIZ A, ZUAZO J, ORTIZ-SANZ C, et al. Sephin1 protects neurons against excitotoxicity independently of the integrated stress response[J]. Int J Mol Sci, 2020, 21(17): E6088.
41	CARRARA M, SIGURDARDOTTIR A, BERTOLOTTI A. Decoding the selectivity of eIF2α holophosphatases and PPP1R15A inhibitors[J]. Nat Struct Mol Biol, 2017, 24(9): 708-716.
42	VAGNARELLI P, ALESSI D R. PP1 phosphatase complexes: undruggable no longer[J]. Cell, 2018, 174(5): 1049-1051.

[1]	谢欣宜, 周薇, 邱澈, 沈慧, 宋忠臣. 伴阿尔茨海默病牙周炎患者血清Th17/Treg相关细胞因子水平变化研究[J]. 上海交通大学学报（医学版）, 2023, 43(5): 600-605.
[2]	杨子豪, 陈楠, 林偲蔚. 数字地形分析方法在大脑皮层形态研究中的应用[J]. 上海交通大学学报（医学版）, 2023, 43(3): 342-349.
[3]	林祎嘉, 程丽珍, 苗雅. 线粒体自噬异常在阿尔茨海默病中的作用及机制研究综述[J]. 上海交通大学学报（医学版）, 2022, 42(3): 387-392.
[4]	王毅, 程诚, 沈红艳, 高红艳, 戴悦宁, 易正辉. 经颅磁刺激对阿尔茨海默病患者认知功能及伴痴呆的行为精神症状疗效的meta分析[J]. 上海交通大学学报(医学版), 2021, 41(7): 931-941.
[5]	陈俊慧, 谷有全, 姚利和, 张薇, 王怀祥. 分子伴侣介导的自噬在阿尔茨海默病中作用的研究进展[J]. 上海交通大学学报(医学版), 2021, 41(11): 1529-1534.
[6]	何海宁，张微，严峰，史琰琛，王静华，肖世富#，王涛#. 阿尔茨海默病引起的轻度认知功能损害的微小RNA表达谱的生物信息学分析[J]. 上海交通大学学报(医学版), 2020, 40(9): 1174-1183.
[7]	张童，张莹林，姚俊岩. 不同测试指标及观测时段对情景条件恐惧实验检测5XFAD转基因小鼠行为学效力的影响[J]. 上海交通大学学报(医学版), 2020, 40(6): 761-767.
[8]	何征晖1，汪泱2，邓志锋3. 干细胞来源的细胞外囊泡修复治疗中枢神经系统疾病的研究进展[J]. 上海交通大学学报（医学版）, 2020, 40(1): 134-.
[9]	王昊 1，江杉 1，龚杨明 2，刘燕 3，华丽 1，邓晓蓓 1. 大气细颗粒物通过嗅球途径导致阿尔茨海默病的机制研究进展[J]. 上海交通大学学报（医学版）, 2019, 39(6): 666-.
[10]	方新宇 1，卢卫红 1，王慧珍 2，倪建良 3，张江涛 3，蔡军 1，李涛 4，张登峰 2，张晨 1. EGR1基因与中国汉族人群阿尔茨海默病发病风险的关联研究[J]. 上海交通大学学报（医学版）, 2019, 39(2): 153-.
[11]	胡梦薇1，李苗苗1，黄婉莹1，王宇1，胡勇博1，张瑞1，侯丽娜1，陈红专1，张永芳1，王领2，谭文2，徐见容1，王昊1. 基于HPLC-MS/MS法的新型双胆碱酯酶抑制剂DDDA3大鼠药代动力学研究[J]. 上海交通大学学报（医学版）, 2019, 39(11): 1233-.
[12]	陈艳 1，方新宇 1，汪也微 1，倪建良 2，张江涛 2，卢卫红 1，李涛 3，张登峰 4，张晨 1. 中国汉族FOS基因 rs1063169多态性与阿尔茨海默病的关联性研究[J]. 上海交通大学学报（医学版）, 2019, 39(1): 47-.
[13]	杨寰庆 1，何祥2，杜晓光 2，肖世富 1，王涛 1. 微环境变化对 PC12细胞淀粉样前体蛋白 β位点裂解酶 1 表达的影响[J]. 上海交通大学学报（医学版）, 2018, 38(9): 1005-.
[14]	胡勇博 1, 2，任汝静 1，王刚 1. Rho相关的卷曲蛋白激酶 1参与 β淀粉样蛋白介导的大鼠原代神经元损伤[J]. 上海交通大学学报（医学版）, 2018, 38(9): 1013-.
[15]	吴依娜 1, 2，庄惠翔 3，李钒 3，刘园园 1, 2，严峰 1, 2，史琰琛 1, 2，王静华 1, 2，张建业 1，刘满华 3，王金红 1，肖世富 1, 2，王涛 1, 2. 阿尔茨海默病的脑微出血特征研究[J]. 上海交通大学学报（医学版）, 2018, 38(8): 917-.

整合应激反应在阿尔茨海默病发病中作用的研究进展

Research progress of integrated stress response in pathogenesis of Alzheimer's disease

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 42

相关文章 15

编辑推荐

Metrics